Prognostic Significance of Potential Immune Checkpoint Member HHLA2 in Human Tumors: A Comprehensive Analysis

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2019.01573
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

HHLA2, a New Immune Checkpoint Member of the B7 Family, Is Widely Expressed in Human Lung Cancer and Associated With EGFR Mutational Status

Clinical Cancer Research
Cancer ResearchOncology
2016English

Prognostic Significance of NEK2 in Human Solid Tumors: A Systematic Review and Meta-Analysis

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2019English

Prognostic Significance of 8-Hydroxy-2′-Deoxyguanosine in Solid Tumors: A Meta-Analysis

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Comprehensive Immunohistochemical Analysis of Immune Checkpoint Molecules in Adult T-Cell Leukemia/Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Retreatment With Immune Checkpoint Inhibitors in Solid Tumors: A Systematic Review

2020English

Prognostic and Clinicopathological Significance of SNHG6 in Human Cancers: A Meta-Analysis

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

The Third Group of the B7-Cd28 Immune Checkpoint Family: HHLA2, TMIGD2, B7x, and B7-H3

Immunological Reviews
AllergyImmunology
2017English

Prognostic Significance of Immune Cells in Non-Small Cell Lung Cancer: Meta-Analysis

Oncotarget
Oncology
2018English

Immune Checkpoint Inhibitors and the Risk of Allograft Rejection: A Comprehensive Analysis on an Emerging Issue

Oncologist
Cancer ResearchMedicineOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy